6T0

1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine

Created:	2016-06-17
Last modified:	2016-07-27

Find Related PDB Entry
2 entries where 6T0 is found as a standalone ligand

Find related ligands: Help
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	34
Chiral Atom Count	0
Bond Count	36
Aromatic Bond Count	15

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine
Systematic Name (OpenEye OEToolkits)	1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine
Formula	C₁₄ H₁₆ N₄
Molecular Weight	240.304
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	CC(C)Cn1cnc2c(N)nc3ccccc3c12
SMILES	OpenEye OEToolkits	2.0.5	CC(C)Cn1cnc2c1c3ccccc3nc2N
Canonical SMILES	CACTVS	3.385	CC(C)Cn1cnc2c(N)nc3ccccc3c12
Canonical SMILES	OpenEye OEToolkits	2.0.5	CC(C)Cn1cnc2c1c3ccccc3nc2N
InChI	InChI	1.03	InChI=1S/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17)
InChIKey	InChI	1.03	DOUYETYNHWVLEO-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB00724
Name	Imiquimod
Description	Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment. Imiquimod does not fight the viruses that cause warts directly, however, it does help to relieve and control wart production. Miquimod is also used to treat a skin condition of the face and scalp called actinic keratoses and certain types of skin cancer called superficial basal cell carcinoma.
Synonyms	Imiquimod 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine 4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline Imiquimodum
Indication	For the topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults. Also indicated for the treatment of external genital and perianal warts/condyloma acuminata in individuals 12 years old and above.
Categories	Adjuvants, Immunologic Aminoquinolines Antineoplastic Agents Cancer immunotherapy Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Substrates Dermatologicals Heterocyclic Compounds, Fused-Ring Immune Response Modifiers Immunologic Factors Immunosuppressive Agents Immunotherapy Increased Cytokine Activity Increased Cytokine Production Interferon Inducers Misc. Skin and Mucous Membrane Agents Quinolines
ATC-Code	D06BB10
CAS number	99011-02-6

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
Toll-like receptor 7	MVFPMWTLKRQILILFNIILISKLLGARWFPKTLPCDVTLDVPKNHVIVD...	unknown	agonist
Toll-like receptor 8	MENMFLQSSMLTCIFLLISGSCELCAEENFSRSYPCDEKKQNDSVIAECS...	unknown	agonist
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682